<DOC>
	<DOCNO>NCT01516008</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy least 1 dose tapentadol IR 50 mg and/or 75 mg versus placebo use sum pain intensity difference 48 hour ( SPID48 ) measure analgesic effect Korean patient acute pain follow bunionectomy .</brief_summary>
	<brief_title>A Study Tapentadol Immediate-Release Treatment Patients With Acute Pain From Bunionectomy</brief_title>
	<detailed_description>This randomize ( study drug assign chance like flip coin ) , double-blind ( neither physician patient know name assign drug ) , placebo-controlled , parallel-group , multicenter study evaluate efficacy safety tapentadol immediate-release ( IR ) 50 mg 75 mg patient undergo bunionectomy ( surgical procedure remove bunion ) . This study design similar study pivotal global study PAI-3003/KF32 order bridge result global study show similarity effect tapentadol Korean Caucasian population allow extrapolation foreign clinical data tapentadol Korea . The study divide screening period , surgical period , qualification period , double-blind treatment period . The study length , include screen period , maximum duration 32 day . Eligible patient randomly assign 1 3 treatment group ( tapentadol IR 50 mg , tapentadol IR 75 mg placebo ) 1:1:1 ratio . Efficacy safety assessment perform study .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Hallux Valgus</mesh_term>
	<criteria>Patients undergo primary unilateral first metatarsal bunionectomy include distal Chevron osteotomy without Akin procedure Healthy medically stable basis clinical laboratory test perform screen . If result outside normal reference range , patient may include investigator judge abnormalities deviation normal clinically significant appropriate reasonable population study Women must postmenopausal , surgically sterile , abstinent , practice agree practice effective method birth control sexually active entry throughout study . Women childbearing potential must negative serum Î² human chorionic gonadotropin pregnancy test screen negative urine pregnancy test surgery If male sexually active , agree use approve method birth control prevent pregnancy female partner donate sperm day first study drug intake 3 month day last study drug intake . To qualify entry doubleblind treatment period , follow criterion must meet : Qualifying baseline pain intensity ( PI ) must rat great equal 4 11point ( 0 to10 ) PI numerical rating scale ( NRS ) , record within 30 minute randomization Qualifying PI must occur early 10 hour first surgical incision Qualifying baseline PI must occur within 9 hour termination systemic analgesia postoperative surgical period History seizure disorder epilepsy suggest presence mild moderate traumatic brain injury , stroke , transient ischemic attack , brain neoplasm within 1 year screening , and/or severe traumatic brain injury , episode ( ) unconsciousness 24 hour duration , posttraumatic amnesia 24 hour duration within 15 year screen History malignancy within past 2 year start study Evidence active infection may spread area body history human immunodeficiency virus 1 2 Clinical laboratory value reflect severe renal insufficiency Moderately severely impair hepatic function , patient abnormal alanine aminotransaminase aspartate aminotransferase Clinical laboratory value outside acceptable limit surgery opinion investigator A clinically significant disease investigator 's opinion may affect efficacy safety assessment Treated anticonvulsant , monoamine oxidase inhibitor , tricyclic antidepressant , neuroleptic , serotonin norepinephrine reuptake inhibitor within 2 week randomization Systemic steroid therapy , exclude inhaler topical steroid , within 4 week screen Women plan become pregnant study , breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Hallux Valgus</keyword>
	<keyword>Bunionectomy</keyword>
	<keyword>Bunion</keyword>
	<keyword>Acute pain</keyword>
	<keyword>Tapentadol</keyword>
	<keyword>Tapentadol IR</keyword>
</DOC>